VIA Pharmaceuticals Inc (VIAP)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC:
*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

750 BATTERY STREET SAN FRANCISCO, CA 94111

VIA Pharmaceuticals is a development stage biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic disease. Co. is developing a pipeline of small molecule drugs that target the causes of cardiovascular and metabolic disease, which includes vascular inflammation, high cholesterol, high triglycerides and insulin sensitization/diabetes. Co.'s lead compound, VIA-2291, is a small molecule drug which is targeted at reducing atherosclerotic plaque inflammation. VIA-2291 is a selective and reversible inhibitor of 5-Lipoxygenase that Co. is developing as a once-daily, oral drug to treat inflammation in the blood vessel wall.

View SEC Filings from VIAP instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
No data found for this quarter.
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding VIAP (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding VIAP BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BAY CITY CAPITAL LLC

BAY CITY CAPITAL FUND IV, L.P.

BAY CITY CAPITAL MANAGEMENT IV LLC

BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP

  • 10% Owner
0 2010-11-15 0

CRAVES FRED B

  • Director
0 2010-11-15 0

GIVEN DOUGLAS B

  • Director
0 2010-11-15 0

WRIGHT KAREN STEIL V.P. ? FINANCE, CONTROLLER

  • Officer
63,826 2010-04-01 0

ANDERSON RICHARD L

  • Director
0 2008-12-17 0

BAGNALL MARK

  • Director
0 2008-12-17 0

HOWARD DAVID T

  • Director
0 2008-12-17 0

LARSON JOHN RANDOLPH

  • Director
0 2008-12-17 0

COHEN LAWRENCE KENNETH CEO AND PRESIDENT

  • Officer
  • Director
419,660 2008-12-17 0

STEWART JAMES GORDON SVP, CFO AND SECRETARY

  • Officer
217,930 2008-12-17 0

TAUB REBECCA SVP, RESEARCH & DEVELOPMENT

  • Officer
157,500 2008-12-05 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments